Home » ETF » IDNA

IDNA - iShares Genomics Immunology and Healthcare ETF

Stock Price: $46.67 USD 1.24 (2.73%)
Updated Apr 21, 2021 4:00 PM EDT - Market closed
Assets $281.98M
NAV $45.48
Expense Ratio 0.47%
PE Ratio 28.20
Beta (5Y) 0.82
Dividend (ttm) $0.12
Dividend Yield 0.26%
Ex-Dividend Date Dec 14, 2020
1-Year Return -
Trading Day April 21
Last Price $46.67
Previous Close $45.43
Change ($) 1.24
Change (%) 2.73%
Day's Open 45.33
Day's Range 45.04 - 46.71
Day's Volume 55,729
52-Week Range 30.46 - 55.03

Fund Description

The investment seeks to track the investment results of the NYSE® FactSet® Global Genomics and Immuno Biopharma IndexTM. The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.

Asset Class
Equity
Inception Date
Jun 11, 2019
Exchange
NYSEARCA
Ticker Symbol
IDNA
Index Tracked
NYSE FactSet Global Genomics and Immuno Biopharma Index

Top 10 Holdings

43.45% of assets
NameSymbolWeight
BeiGene Ltd Ordinary Shares6160.HK5.86%
ExelixisEXEL4.99%
Fate TherapeuticsFATE4.88%
Gilead SciencesGILD4.31%
Merck KGaAMRK.DE4.20%
Sanofi SASAN.PA3.99%
Regeneron PharmaceuticalsREGN3.96%
BioNTech SEBNTX3.82%
Takeda Pharmaceutical Co Ltd4502.T3.77%
Evotec SEEVT.DE3.66%
View More Holdings

Dividends

Ex-DividendAmountPay Date
Dec 14, 2020$0.036Dec 18, 2020
Jun 15, 2020$0.084Jun 19, 2020
Full Dividend History

News

Hide News
  • All
  • Videos
  • Conversation

As investors re-allocate in 2021, it is critical to look past the headlines to the overarching themes that will propel our economy into the future. Investors cannot afford to miss developments like digi...

Other tickers mentioned: IRBO
4 weeks ago - ETF Trends

The best biotech ETFs for Q2 2021 are ARKG, IDNA, and XBI.

Other tickers mentioned: ARKG, XBI
2 months ago - Investopedia

The coronavirus pandemic triggered a race to introduce vaccine and treatment, thereby opening up new investing opportunities in the biotech sector in 2020.

Other tickers mentioned: ARKG, BTEC, GNOM, XBI
3 months ago - Zacks Investment Research

Megatrends To Invest In Now: 3 Best ETF Picks

YouTube video

BlackRock has identified five big trends that are here to stay for the long haul. Investors can get exposure to these drivers via 17 iShares ETFs.

Other tickers mentioned: ICLN, IDRV
4 months ago - Investors Business Daily

ETF investors looking ahead to 2021 tend to seek out current trends, but the megatrends run much deeper. These are the large-scale undercurrents that can disrupt a whole sector.

4 months ago - ETF Trends

The best biotech ETFs for Q1 2021 are ARKG, BTEC, and IDNA.

Other tickers mentioned: ARKG, BTEC
5 months ago - Investopedia

The election year and the coronavirus has highlighted the importance of an adaptive health industry that meets up with quickly changing times. Investors can also tap into this evolution in healthcare th...

Other tickers mentioned: IBB
5 months ago - ETF Trends

Genomics ETFs have surged of late; here's why

Other tickers mentioned: ARKG, GNOM
6 months ago - Zacks Investment Research

The announcement of the 2020 Nobel Prize winners for Chemistry has successfully brought investor attention to the gene-editing space.

Other tickers mentioned: ARKG, GNOM, PBE
6 months ago - Zacks Investment Research

The healthcare sector defied last week's market rout buoyed by the progress in the development of a coronavirus vaccine or treatment, and merger and acquisition news.

Other tickers mentioned: BBC, BTEC, IBBJ, MRNS, NVUS, PTH, SAVA ...
7 months ago - Zacks Investment Research

Per the latest data from an early stage clinical trial, Moderna's experimental coronavirus vaccine is successfully producing neutralizing antibodies and T-cells in older adults.

Other tickers mentioned: BBH, BTEC, CNCR, GERM, IBB, XBI
7 months ago - Zacks Investment Research

Small-cap biotech ETFs may prove to be winning bets with or without coronavirus.

Other tickers mentioned: BBC, BTEC, IBBJ
7 months ago - Zacks Investment Research

Moderna plans to begin the Phase 3 study of mRNA-1273 this month.

Other tickers mentioned: MRNA, BBH, BTEC, CNCR, FBT, GERM, IBB ...
9 months ago - Zacks Investment Research

From vaccine-related progress to development of cell therapies for the treatment of coronavirus, all kept the rally in the biotech sector alive.

Other tickers mentioned: ARKG, BIB, XBI
9 months ago - Zacks Investment Research

In this episode of ETF Spotlight, I speak with Jeff Spiegel, U.S. Head of Megatrends and International ETFs at BlackRock, about megatrend investing.

Other tickers mentioned: GILD, IHAK, IRBO, MRNA, REGN
9 months ago - Zacks Investment Research

Here we highlight some ETFs for gaining exposure to the genomics market that is currently buzzing with opportunities for investors to cash on.

Other tickers mentioned: ARKG, GNOM, PBE
10 months ago - Zacks Investment Research

Shares of biotechnology company Moderna Inc (NASDAQ: MRNA) jumped 20% Monday on news that its mRNA-1273 coronavirus vaccine candidate is making positive progress.

Other tickers mentioned: BTEC, CNCR
11 months ago - Benzinga

ETF Edge: Big boost for energy ETF

YouTube video

CNBC's Bob Pisani breaks down the biggest exchange-traded funds moves.

Other tickers mentioned: JETS, XOP
11 months ago - CNBC Television

Biotech and healthcare ETFs were pretty stable on Apr 23 despite the news that Gilead's Remdesivir failed to improve Covid-19 patients' condition.

Other tickers mentioned: BBH, CNCR, FBT, IBB, IHE, IHF, PBE ...
11 months ago - Zacks Investment Research

While biotech stocks are often too risky for many investors, with the coronavirus raging and the race for a vaccine in play, taking a look at some ETFs that contain biotech stocks that are making stride...

Other tickers mentioned: IBB
1 year ago - ETF Trends

Growing coronavirus concerns provide some support to these biotech ETFs and stocks amid a massive market sell-off.

Other tickers mentioned: ARKG, AYTU, BBH, CNCR, CNTG, CODX, FTSV ...
1 year ago - Zacks Investment Research

An oil collapse sent Wall Street into a tailspin on Mar 9, indicating that the 11-year-long bull market might soon end. These ETFs may, however, survive the crash.

Other tickers mentioned: CLIX, PSK
1 year ago - Zacks Investment Research

These sector ETFs gained or lost the least in the coronavirus-induced rout in February.

Other tickers mentioned: CLIX, GLD, KURE, SGDM
1 year ago - Zacks Investment Research

Can biotech ETFs repeat its success story of 2019 in the election year of 2020?

Other tickers mentioned: BBC, CNCR, HTEC, IBB, PBE, SBIO, XBI
1 year ago - Zacks Investment Research